How is Pfizer Tackling the “Blockbuster Drug Drought” in the Post-Pandemic Era? Mar 17, 2026 Life Science
Insider Cashes Out, Hedge Fund Piles In: The Two Faces of Olema After a 300% Rally Mar 16, 2026 Life Science
Novo Nordisk Partners with Hims & Hers: Can Turning a Foe into a Friend Reverse the Downturn? Mar 13, 2026 Life Science
Why Microsoft Is a Safe Bet in the AI Era, Despite Moderate Stock Gains Mar 13, 2026 Life Science, Technology
Seeking a Bottom in Choppy Markets? Two Long-Term Picks with “Anti-Fragile” Qualities Mar 12, 2026 Life Science, Technology
The Obesity Drug War Goes Oral: Why Eli Lilly’s Orforglipron Could Steal the Spotlight from Novo Mar 11, 2026 Life Science
This Stock Soared 1600% in a Year! Billionaire Cohen Had Already Positioned Himself Mar 11, 2026 Life Science
A Tenfold Increase in a Decade? What Makes This Small Biotech Company So Special Mar 10, 2026 Life Science
Novo Nordisk’s Price Cuts and R&D Progress Go Hand in Hand, GLP-1 Drug Prices Reduced by Up to 50% Mar 10, 2026 Life Science
$70 Billion and Counting: The 5 US Dividend Giants That Keep on Giving Mar 9, 2026 Energy, Financial Service, Life Science, Technology
This Cathie Wood-Favored Gene-Editing Stock Is Up 47% This Year. Is It Poised to Take Off? Mar 8, 2026 Life Science
Clinical Data Optimism Combined with Analyst Recommendation Drives Shattuck Labs Shares Up 53% This Week Mar 6, 2026 Life Science
A Dividend Yield of Up to 4% and 48 Consecutive Years of Increases, Watch These Two Healthcare Giants Mar 6, 2026 Life Science
